US PREMARKET MOVERS: ACN, WBD, PSKY, NVO, CRML, MP, CIEN, TLX, ALKS
US premarket trading on September 21, 2026, saw significant moves across corporate acquisitions, regulatory discussions, partnerships, target announcements, and clinical study developments.
News detail
ACN +4.7%: Partnering with Anthropic to establish a team of embedded evaluators. WBD +7.2%, PSKY +6.2%: PSKY and California’s AG are discussing settlement concessions over a lawsuit that is blocking the merger between PSKY & WBD. NVO -4.9%: 2030 targets disappoint. CRML +25.3%: Clear Street argues Trump-Greenland agreement could accelerate Critical Metals’ Tanbreez development. MP +3.3%: China Rare Earth Group is reportedly in talks to acquire control of Shenghe Resources, which holds a 3% stake in MP. CIEN +6.2%: Upgraded at Evercore ISI to Outperform from In Line. TLX -10.0%: Agreed to acquire ITM Isotope Tech Munich for $1.65B. ALKS +8.3%: Orexin agonist reportedly shows potential to treat ADHD in early-stage trial.
Related stocks
9 stocks
ACNAccenture PLC$188.61Current price
WBDWarner Bros. Discovery, Inc. Series A Common Stock$29.82Current pricePSKYParamount Skydance Corporation Class B Common Stock$10.78Current price
NVONovo-Nordisk A/S$40.57Current price
CRMLCritical Metals Corp. Ordinary Shares$9.12Current price
MPMP Materials Corp.$49.31Current price
CIENCiena Corporation$364.17Current price
TLXTelix Pharmaceuticals Limited American Depositary Shares$11.29Current price
ALKSAlkermes Inc. plc$43.65Current priceWhat do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.